These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 8147907
21. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells. Dorr RT, Liddil JD, Soble MJ. Invest New Drugs; 1986; 4(4):305-13. PubMed ID: 3583642 [Abstract] [Full Text] [Related]
22. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs. Thrall BD, Raha GA, Springer DL, Meadows GG. Pigment Cell Res; 1991 Dec; 4(5-6):234-9. PubMed ID: 1823927 [Abstract] [Full Text] [Related]
23. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma. Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC. Chem Biol Interact; 1998 Apr 24; 111-112():277-305. PubMed ID: 9679561 [Abstract] [Full Text] [Related]
24. Glutathione-dependent biotransformation of the alkylating drug thiotepa and transport of its metabolite monoglutathionylthiotepa in human MCF-7 breast cancer cells. Cnubben NH, Rommens AJ, Oudshoorn MJ, Van Bladeren PJ. Cancer Res; 1998 Oct 15; 58(20):4616-23. PubMed ID: 9788613 [Abstract] [Full Text] [Related]
25. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC. Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674 [Abstract] [Full Text] [Related]
26. A glutathione depletion selectively imposed on mu glutathione S-transferase overproducing cells increases nitrogen mustard toxicity. Lunel-Orsini C, Buttin G, De Saint Vincent BR. Biochem Pharmacol; 1995 Jan 31; 49(3):329-38. PubMed ID: 7857320 [Abstract] [Full Text] [Related]
27. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells. Ripple M, Mulcahy RT, Wilding G. J Urol; 1993 Jul 31; 150(1):209-14. PubMed ID: 8510259 [Abstract] [Full Text] [Related]
28. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B. Cancer Res; 1988 Jan 01; 48(1):19-26. PubMed ID: 3334994 [Abstract] [Full Text] [Related]
29. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG. Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477 [Abstract] [Full Text] [Related]
30. Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism. Lewis AD, Durán GE, Lau DH, Sikic BI. Int J Radiat Oncol Biol Phys; 1992 Dec 15; 22(4):821-4. PubMed ID: 1544857 [Abstract] [Full Text] [Related]
31. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy. Siemann DW, Beyers KL. Br J Cancer; 1993 Dec 15; 68(6):1071-9. PubMed ID: 8260357 [Abstract] [Full Text] [Related]
32. Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line. Canada A, Herman L, Kidd K, Robertson C, Trump D. Cancer Chemother Pharmacol; 1993 Dec 15; 32(1):73-7. PubMed ID: 8462127 [Abstract] [Full Text] [Related]
33. Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion. Tsai-Turton M, Luong BT, Tan Y, Luderer U. Toxicol Sci; 2007 Jul 15; 98(1):216-30. PubMed ID: 17434952 [Abstract] [Full Text] [Related]
34. Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms. Zhang K, Chew M, Yang EB, Wong KP, Mack P. Mol Pharmacol; 2001 Apr 15; 59(4):837-43. PubMed ID: 11259628 [Abstract] [Full Text] [Related]
35. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. Dusre L, Mimnaugh EG, Myers CE, Sinha BK. Cancer Res; 1989 Feb 01; 49(3):511-5. PubMed ID: 2535960 [Abstract] [Full Text] [Related]
36. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents. Townsend AJ, Tu CP, Cowan KH. Mol Pharmacol; 1992 Feb 01; 41(2):230-6. PubMed ID: 1538704 [Abstract] [Full Text] [Related]
37. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance. Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM, Davidson NE. Cancer Res; 1992 Mar 15; 52(6):1416-21. PubMed ID: 1540950 [Abstract] [Full Text] [Related]
38. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro. Perry RR, Greaves BR, Rasberry U, Barranco SC. Cancer Res; 1992 Sep 01; 52(17):4608-12. PubMed ID: 1511428 [Abstract] [Full Text] [Related]
39. Schisandrin B-induced increase in cellular glutathione level and protection against oxidant injury are mediated by the enhancement of glutathione synthesis and regeneration in AML12 and H9c2 cells. Chiu PY, Ko KM. Biofactors; 2006 Sep 01; 26(4):221-30. PubMed ID: 17119269 [Abstract] [Full Text] [Related]
40. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line. Chao CC, Huang YT, Ma CM, Chou WY, Lin-Chao S. Mol Pharmacol; 1992 Jan 01; 41(1):69-75. PubMed ID: 1346333 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]